| Breakdown | TTM | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 11.87B | 11.80B | 11.27B | 12.50B | 12.41B | 12.97B |
| Gross Profit | 4.57B | 4.54B | 4.09B | 4.99B | 5.31B | 5.36B |
| EBITDA | 1.72B | 1.73B | 1.36B | 2.32B | 2.68B | 2.87B |
| Net Income | 547.28M | 550.86M | 298.28M | 873.06M | 1.31B | 1.55B |
Balance Sheet | ||||||
| Total Assets | 13.02B | 13.20B | 12.52B | 12.97B | 12.45B | 11.84B |
| Cash, Cash Equivalents and Short-Term Investments | 7.69B | 7.83B | 6.86B | 7.85B | 7.29B | 6.53B |
| Total Debt | 28.57M | 59.38M | 108.39M | 172.74M | 211.28M | 321.93M |
| Total Liabilities | 2.26B | 2.14B | 1.65B | 2.04B | 2.08B | 2.68B |
| Stockholders Equity | 10.31B | 10.56B | 10.41B | 10.51B | 10.01B | 8.87B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | 1.97B | 649.95M | 1.67B | 1.63B | 1.97B |
| Operating Cash Flow | 0.00 | 2.09B | 812.01M | 1.80B | 1.85B | 2.07B |
| Investing Cash Flow | 0.00 | -617.28M | -1.31B | -747.07M | -784.22M | -774.50M |
| Financing Cash Flow | 0.00 | -500.16M | -492.92M | -495.90M | -301.54M | 3.21B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
77 Outperform | ¥195.47B | 16.53 | ― | 1.17% | 53.21% | 65.83% | |
72 Outperform | ¥15.55B | 15.11 | ― | 1.96% | 0.16% | 116.15% | |
67 Neutral | ¥9.37B | 12.72 | ― | 3.92% | 2.87% | 27.30% | |
62 Neutral | ¥10.43B | 32.07 | ― | 0.91% | 8.13% | 275.53% | |
60 Neutral | $48.67B | 4.58 | -11.27% | 4.14% | 2.83% | -41.78% | |
52 Neutral | ¥54.14B | 6.12 | 4.10% | 4.16% | 11.52% | 162.04% | |
46 Neutral | ¥4.87B | -42.70 | ― | ― | -2.84% | 36.23% |